Filing Flows › Korsana Biosciences (KRSA) › Q3 2025 › vs Q2 2025
Korsana Biosciences (KRSA) Q3 2025 vs Q2 2025 (quarter over quarter)
Korsana Biosciences's revenue rose $782K (+841%) from $93K in Q2 2025 to $875K in Q3 2025.
Korsana Biosciences, Q3 2025: revenue $875K (+351% year over year), operating margin -115.0%, net loss $976K, operating cash flow −$264K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q3 2025 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $875K | $93K | $782K | +841% |
| Other income, net | $30K | $1.3M | −$1.3M | -98% |
| Net loss | $976K | $324K | $652K | +201% |
| Costs & expenses | $1.9M | $1.8M | $116K | +7% |
| Operating costs | $1.9M | $1.8M | $116K | +7% |
| Research & development | $348K | $56K | $292K | +521% |
| General & admin | $1.5M | $1.7M | −$176K | -10% |
| Operating cash sources | $976K | $324K | $652K | +201% |
| Share-based compensation | $118K | $114K | $4K | +4% |
| Working capital & other | $594K | −$293K | $887K | — |
| Cash used in operations | $264K | $503K | −$239K | -48% |
| Net loss absorbed | $976K | $324K | $652K | +201% |
Questions
How much did Korsana Biosciences's revenue grow quarter over quarter in Q3 2025?
Korsana Biosciences's revenue rose $782K (+841%) from $93K in Q2 2025 to $875K in Q3 2025.